Investor Information

Press Releases

Resources

Legal Disclaimer

INVESTOR INFORMATION


PHARMAROTH LABS, INC. (OTC: ROTH)

PharmaRoth Labs Inc. (OTC: ROTH) is focused on diabetes prevention and treatments. The Company holds the intellectual property and other exclusive world-wide rights related to the production, marketing, and distribution of SucanonĀ®, a oral treatment for Type II diabetes.

RECENT NEWS

July 23, 2014
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China

April 16, 2014
PharmaRoth Labs, Inc. Announces Mexican Distributor Surpasses Sales Goal

March 24, 2014
PharmaRoth Labs, Inc. Announces Retails and Wholesale Distribution Channels in Mexico

March 17, 2014
PharmaRoth Labs, Inc. Announces Results From FDA Application

STOCK INFORMATION
OTC: ROTH


CONTACTS

Stock Transfer Agent:
Pacific Stock Transfer
4045 S. Spencer Street
Suite 403
Las Vegas, NV 89119
702-361-3033
www.pacificstocktransfer.com

Investor Relations:
IR@PharmaRoth.com


Home  |  Company  |  Diabetes  |  Sucanon  |  Investor Relations  |  Contact  |  Legal Disclaimer  |  Privacy Policy